摘要
目的:探讨轻度认知功能障碍(Mild Cognitive Impairmem,MCI)患者血浆蛋白磷酸酯酶-2A(protein phosphotaae-2A,PP-2A)的活性变化。方法:用放射性配体结合实验检测不同病程MCI患者及正常老年人对照组血浆PP-2A的活性变化。结果:1年MCI组(0.94±0.09)PP-2A的活性与对照组(1.01±0.08)比较无明显降低(P>0.05),而2年MCI组(0.89±0.07)及3年MCI组(0.86±0.10)血浆PP-2A活性与对照组相比明显降低(P<0.05,P<0.01),与1年MCI组的PP-2A的活性比较无明显差别(P>0.05)。结论:病程延长的MCI患者血浆PP-2A的活性降低,对MCI的诊断可能有潜在的价值。
Objective : Our purpose was to explore the alteration of protein phosphotase-2A (PP-2A) activities in plasma of the patients with mild cognitive impairment. Methods:the activities of PP-2A was measured by by 32P liquid scintillography for incorporated radioactivity in control group,1-year MCI group ,2-year MCI group and 3-year MCI group. Results L the activities of PP-2A in 1-year MCI group(0. 94 ±0. 09) and was not obviously lower as compared with control group ( 1.01 ± 0. 08) ( P 〉 0, 05 ), bat a difference was induced in 2-year MCI group (0. 89 ± 0. 07 ) and 3-year MCI group (0. 86 ± 0. 10 ) as compared with control group( P 〈 0. 05, P 〈 0, 01 ). There was not an obvious difference among these three MCI groups ( P 〉 0.05 ). Conclusions :Lower activities of PP-2A in plasma imply a possible value of MCI diagnosis.
出处
《中国医药导刊》
2009年第5期804-805,共2页
Chinese Journal of Medicinal Guide
基金
中国博士后基金资助项目(20060390635)
上海市浦东新区社发局基金资助项目(PW2008A-8)